CLINICAL TRIAL CONSENTS:

ACTG Studies

 

CFAR Query Request Form

Pre-Screen IC V2 4/12/16 *EFFECTIVE 4/18/16

Cryopreservation IC V9 1/25/10 *EFFECTIVE 6/1/16

A5128 V4 IC V8 4/2/13 *EFFECTIVE 10/10/16

A5315 V3 Cohort 4 IC V1 10/19/16 *EFFECTIVE 11/21/16

A5320 V2 IC V7 11/11/16 *EFFECTIVE 12/1/16

A5321 V2 IC V7 6/7/16 *EFFECTIVE 7/25/16

A5322 V2 IC V5 2/25/16 *EFFECTIVE 8/4/16

A5324 V1 IC V3 2/11/16 *EFFECTIVE 8/9/16

SPIRIT V1 IC V1 7/13/16 *EFFECTIVE 10/25/16

A5329 V2 IC V4 7/26/16 *EFFECTIVE 9/6/16

A5332 V3 IC V7 9/7/16 *EFFECTIVE 10/11/16

A5333s V3 IC V4 9/7/16 *EFFECTIVE 10/11/16

A5335s V1 IC V2 3/22/16 *EFFECTIVE 4/1/16

A5336 V2 IC V3 10/5/16 *EFFECTIVE 10/26/16

A5341s V1 IC V3 9/1/16 *EFFECTIVE 9/8/16

A5350 V1 IC V3 3/15/16 *EFFECTIVE 3/31//16

A5353 V1 IC V2 10/21/15 *EFFECTIVE 10/10/16

Cocaine Use PET Scan IC V3 2/25/14 *EFFECTIVE 11/21/16

Industry Studies

BMS AI438047 IC V3 6/30/15 *EFFECTIVE 11/2/15

BMS AI438047 PG IC V1 1/26/15 *EFFECTIVE 11/2/15

BMS AI438047 Addendum IC V1 5/27/16 * EFFECTIVE 6/21/16

BMS AI438047 Letter 5/27/16 *EFFECTIVE 6/21/16

EBOV-001 IC V3 6/30/16 *EFFECTIVE 8/8/16

Ebola Plasma IC V2 7/21/16 *EFFECTIVE 8/1/16

EV Biomarkers - Dr. Mohler IC V2 3/16/16 *EFFECTIVE 6/21/16

Gilead US248-0122 IC4 8/12/14 *EFFECTIVE 7/25/16

Gilead US248-0123 IC4 8/12/14 *EFFECTIVE 9/22/16

Gilead US292-0104 IC7 1/23/15 *EFFECTIVE 3/5/15

Gilead US292-0109 IC6 3/5/15 *EFFECTIVE 4/7/15

Gilead US292-0109 FIGHT DEXA IC2 5/15/13 *EFFECTIVE 7/17/13

Gilead US292-0111 IC5 1/24/15 *EFFECTIVE 3/5/15

Gilead US292-0112 IC8 11/5/15 *EFFECTIVE 12/14/15

Gilead US292-0112 PK/PD IC1 8/20/13 *EFFECTIVE 10/7/13

Gilead US366-1160 IC 6/16/16 *EFFECTIVE 6/20/16

Gilead US366-1160 IC 8/17/16 *EFFECTIVE 9/1/16

Gilead US366-1160Addendum IC 8/4/16 *EFFECTIVE 8/17/16

Gilead US366-1216 IC 6/16/16 *EFFECTIVE 6/20/16

Gilead US366-1216 IC 8/17/16 *EFFECTIVE 9/1/16

Gilead US366-1216 Addendum IC 8/4/16 *EFFECTIVE 8/17/16

Gilead US366-1216 Dexa IC 5/13/16 *EFFECTIVE 6/20/16

Gilead US366-1992 IC 7/14/16 *EFFECTIVE 7/14/16

Gilead US366-1992 Pregnancy IC 9/20/16 *EFFECTIVE 10/19/16

Gilead US380-1489 IC 11/4/16 *EFFECTIVE 11/9/16

Gilead US380-1489 Triumeq Insert *EFFECTIVE 4/22/16

Gilead US380-1489 Pregnancy IC 11/3/15 *EFFECTIVE 12/9/15

Gilead US380-1490 IC 2/26/16 *EFFECTIVE 3/2/16

Gilead US380-1490 Tivicay Insert *EFFECTIVE 4/22/16

Gilead US380-1490 Pregnancy IC 11/3/15 *EFFECTIVE 12/10/15

IRC005 V2 IC V6 10/27/16 *EFFECTIVE 12/1/16

Jean Boyer Venipuncture Study IC V5 5/24/12 *EFFECTIVE 1/14/15

Leukapheresis - Reservoirs IC V2 12/1/15 *EFFECTIVE 10/12/16

Merck MK-1436A-021 IC 6/9/16 *EFFECTIVE 6/13/16

Merck MK-1436A-021 FBR IC 6/16/15 *EFFECTIVE 6/22/15

Merck MK-1436A-024 IC 7/13/16 *EFFECTIVE 7/15/16

Merck MK-1436A-024 ext IC 5/26/16 *EFFECTIVE 6/15/16

Merck MK-1436A-024 Clincard IC 1/27/15 *EFFECTIVE 9/26/16

Merck MK-1436A-024 Clincard ext IC 1/27/15 *EFFECTIVE 11/7/16

Merck MK-1436A-024 FBR IC 6/16/15 *EFFECTIVE 6/22/15

Pfizer Poem A4001067 IC V5 3/21/12 *EFFECTIVE 2/28/13

Pfizer Poem A4001067 Pregnancy Partner Release *EFFECTIVE 11/4/16

Sangamo (znf) LTFU V4 1/8/14 *EFFECTIVE 10/12/15

Sangamo II (m-rna) LTFU V3 7/22/16 *EFFECTIVE 9/26/16

Sangamo SB-728mR Cohort 1 V11 9/10/15 *EFFECTIVE 11/2/15

Sangamo SB-728mR Cohort 2/3 V2 2/9/16 *EFFECTIVE 7/25/16

Virxsys/Adapt LTFU 3/30/12 - *EFFECTIVE 7/7/16

VRC 500 IC V1 7/12/16 - *EFFECTIVE 12/5/16

Zika-001 V1.1 6/13/16 - *EFFECTIVE 7/21/16

Zika Plasma IC V2 10/21/16 - *EFFECTIVE 10/28/16

 
 

About Penn Medicine   Contact Us   Site Map   Privacy Statement   Legal Disclaimer   Terms of Use

Penn Medicine, Philadelphia, PA 800-789-PENN © 2016, The Trustees of the University of Pennsylvania